Please provide your email address to receive an email when new articles are posted on . Outset Medical, maker of the Tablo hemodialysis machine, reported that the device was added to 30 new hospital ...

Please provide your email address to receive an email when new articles are posted on . Outset Medical Inc. reported in a recent 8-K filing that it had received a warning letter from the FDA ...

Outset Medical’s Tablo hemodialysis system was cleared by the FDA for at-home use in March 2020. The company said it has since made changes to the device that necessitate a follow-up FDA review.

Outset Medical, Inc. OM recently announced that its next-generation Tablo hemodialysis system has received 510(k) clearance, marking a key regulatory milestone for the company. The clearance positions ...

Outset Medical has raised $76.5 million in a series C round led by T. Rowe Price Associates. In addition to new investor T. Rowe Price Associates, existing investors Fidelity Management & Research ...

With an FDA clearance in hand, Outset Medical saw its stock soar nearly 60% at its peak, before the share price settled to a healthy 20% gain by the end of the day, to ultimately land at $3.79.

The Tablo System promises to make dialysis easier and more convenient for patients. But there are significant barriers to the technology. By Dawn MacKeen This article is part of Upstart, a series ...

WHITMORE LAKE, Mich.--(BUSINESS WIRE)--Trace Medical, the national leader in advanced respiratory rentals and biomedical services, has announced a long-term distribution agreement with Outset Medical ...

Tablo on Great Day Live! Click here, to learn more information.

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”) announced today that the Strategic Acquisition Center (SAC) Office of Procurement, Department of Veterans Affairs ...